Articles by admin

No Picture
Trading Ideas

Nio Rising On Record-High Monthly Deliveries, Goldman Sachs Upgrade

June 4, 2020 admin Comments Off on Nio Rising On Record-High Monthly Deliveries, Goldman Sachs Upgrade

China’s electric vehicle maker Nio Inc (NIO) has revealed that it delivered 3,436 vehicles in May 2020, representing a strong 215.5% growth year over year. Shares are now rising 3% in Thursday’s pre-market trading.The deliveries consisted of 2,685 ES6s, the company’s 5-seater high-performance premium smart electric SUV, and 751 ES8s, the company’s 7-seater high-performance premium smart electric SUV and its 6-seater variant.As of May 31, 2020, cumulative deliveries of the ES8 and the ES6 reached 42,342 vehicles, of which 10,429 were delivered in 2020, NIO said.“In May, we achieved record-high monthly deliveries in our history” cheered William Bin Li, founder …read more […]

No Picture
Trading Ideas

The Three Things That Explain This National Crisis

June 4, 2020 admin Comments Off on The Three Things That Explain This National Crisis

We picked up our pen and scratched our head this morning.
We struggled with what to write you about. It’s not that we don’t have any thoughts. It’s just the opposite.
First, we wanted to write a piece begging folks to put some money into the stock market. We’ve never seen Mr. Market so eager to make folks rich.
But we’ve already mused about that idea… here, here and here.
(We even gave away one of our top picks here.)
We’re wary that if you haven’t already taken the advice, you may not want to hear it again.
And then we thought we’d join the national …read more […]

No Picture
Trading Ideas

Inovio Suing Suppliers Over Covid-19 Vaccine Production

June 4, 2020 admin Comments Off on Inovio Suing Suppliers Over Covid-19 Vaccine Production

Inovio Pharmaceuticals (INO) has now initiated legal proceedings as an emergency action to compel the technology transfer required for the planned large-scale manufacture of its COVID-19 vaccine candidate.The company has an ambitious goal of producing one million doses of INO-4800 by the end of 2020, with its existing capacity and contract resources, for further clinical trials or emergency use.To fulfil this goal, INO has filed a complaint in Pennsylvania to compel VGXI, Inc. and GeneOne Life Science to facilitate the transfer of manufacturing methods, using VGXI’s technology, to the company’s new engaged contract manufacturers.“The Company believes that widespread availability of …read more […]